Patents by Inventor Miriam Torchinsky

Miriam Torchinsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9233154
    Abstract: The present invention relates to compositions and methods for the modulation of TH17 responses. The invention provides compositions for the induction of TH17 responses containing a TLR agonist and an apoptotic cell-associated agent or containing a microbe-infected apoptotic cell. The compositions of the present invention may also contain dendritic cells capable of inducing TH17 responses. In other embodiments, the invention provides compositions for the inhibition of TH17 responses containing one or more blocking agents. Methods and compositions for the modulation of TH17 responses and for the treatment of TH17-associated diseases and for cancer are also provided.
    Type: Grant
    Filed: December 13, 2013
    Date of Patent: January 12, 2016
    Assignee: Icahn School of Medicine at Mount Sinai
    Inventors: Julie Magarian Blander, Miriam Torchinsky
  • Publication number: 20140178400
    Abstract: The present invention relates to compositions and methods for modulation of TH17 responses. The invention provides compositions for the induction of TH17 responses containing a TLR agonist and an apoptotic cell-associated agent or containing a microbe-infected apoptotic cell. The compositions of the present invention may also contain dendritic cells capable of inducing TH17 responses. In other embodiments, the invention provides compositions for the inhibition of TH17 responses containing one or more blocking agents. Methods and compositions for the modulation of TH17 responses and for the treatment of TH17-associated diseases and for cancer are also provided.
    Type: Application
    Filed: December 13, 2013
    Publication date: June 26, 2014
    Inventors: Julie Magarian Blander, Miriam Torchinsky
  • Patent number: 8628762
    Abstract: The present invention relates to compositions and methods for the modulation of TN 17 responses. The invention provides compositions for the induction of TN 17 responses containing a TLR agonist and an apoptotic cell-associated agent or containing a microbe-infected apoptotic cell. The compositions of the present invention may also contain dendritic cells capable inducing TN 17 responses. In other embodiments, the invention provides compositions for the inhibition of TN 17 responses containing one or more blocking agents. Methods and compositions for the modulation of TN 17 responses and for the treatment of TN 17-associated diseases and for cancer are also provided.
    Type: Grant
    Filed: December 9, 2009
    Date of Patent: January 14, 2014
    Assignee: Icahn School of Medicine at Mount Sinai
    Inventors: Julie Magarian Blander, Miriam Torchinsky
  • Publication number: 20120039841
    Abstract: The present invention relates to compositions and methods for the modulation of TN 17 responses. The invention provides compositions for the induction of TN 17 responses containing a TLR agonist and an apoptotic cell-associated agent or containing a microbe-infected apoptotic cell. The compositions of the present invention may also contain dendritic cells capable inducing TN 17 responses. In other embodiments, the invention provides compositions for the inhibition of TN 17 responses containing one or more blocking agents. Methods and compositions for the modulation of TN 17 responses and for the treatment of TN 17-associated diseases and for cancer are also provided.
    Type: Application
    Filed: December 9, 2009
    Publication date: February 16, 2012
    Applicant: MOUNT SINAI SCHOOL OF MEDICINE
    Inventors: Julie Magarian Blander, Miriam Torchinsky